Position in PBYI
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$204,891
+$43,455 QoQ
Shares Held
25,264
0.0% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#75
of 160 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Metis Global Partners, LLC holds $12,809,533 across 8 Biotechnology names. PBYI ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,929 | $5,428,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
59,374 | $3,329,100 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,439 | $1,520,814 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,009 | $1,206,829 | |
| 5 | INCY |
Incyte Corp
|
4,068 | $461,148 | |
| 6 | MRNA |
Moderna, Inc.
|
6,452 | $451,833 | |
| 7 | TECH |
BIO-TECHNE Corp
|
2,918 | $206,156 | |
| 8 | PBYI |
Puma Biotechnology, Inc.
This page
|
25,264 | $204,891 |
All Filings in PBYI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,891 | 25,264 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $161,436 | 25,264 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $253,386 | 42,586 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $296,287 | 55,798 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $191,387 | 55,798 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $126,563 | 42,758 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $120,557 | 39,527 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $100,793 | 39,527 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $128,858 | 39,527 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $209,493 | 39,527 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||